연구동향 분석

대사증후군 예측인자로서 알라닌아미노전이효소의 의미

권지혜 안용성 강양호 손석만 김인주 김용기 2008년

논문상세정보
인용/피인용

' 대사증후군 예측인자로서 알라닌아미노전이효소의 의미' 의 참고문헌

  • Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III)
    Liangpunsakul S Am J Med Sci 329 111-116 [2005]
  • The prevalence and etiology of elevated aminotransferase levels in the United States
    Clark JM Am J Gastroenterol 98 960-967 [2003]
  • Serum r-glutamyltrans- ferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men
    Nakanishi N Diabetes Care 27 1427-1432 [2004]
  • Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans
    Choi KM Clin Endocrinol 61 75-80 [2004]
  • Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study
    Han TS Diabetes Care 25 2016-2021 [2002]
  • Prevalence of metabolic syndrome according to the new criteria for obesity
    Chung HW J Kor Diabetes Assoc 26 431-442 [2002]
  • Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
    Browning JD Hepatology 40 1387-1395 [2004]
  • Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
    Marchesini G Hepatology 37 917-923 [2003]
  • Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
    Marchesini G Diabetes 50 1844-1850 [2001]
  • Non-alcoholic fatty liver disease: an overview
    Mulhall BP J Gastroenterol Hepatol 17 1136-1143 [2002]
  • Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome
    Laaksonen DE Diabetes Care 25 1612-1628 [2002]
  • Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study
    Hanley AJ Diabetes 54 3140-3147 [2005]
  • Homeostatic model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentration in man
    Matthews DR Diabetologia 28 412-419 [1985]
  • Hepatic enzyme, the metabolic syndrome, and the risk of type 2 diabetes in older men
    Wannamethee SG Diabetes Care 28 2913-2918 [2005]
  • Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged man and women, data from the Epidemiological Study on the Insulin Resistance Syndrome(DESIR) cohort
    Andre P Diabetes Care 30 2355-2361 [2007]
  • Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
    Seppala-Lindroos A J Clin Endocrinol Metab 87 3023-3028 [2002]
  • Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    JAMA 285 2486-2496 [2001]
  • Evaluation of abnormal liver-enzyme results in asymptomatic patients
    Pratt DS Engl J Med 342 1266-1271 [2000]
  • Elevated alanine aminotranferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevaention Study
    Sattar N Diabetes 53 2855-2860 [2004]
  • Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content
    Tiikkainen M Diabetes 52 701-707 [2003]
  • Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes?
    Lee DH Diabetologia 51 402-407 [2008]
  • Abnormal liver function test predicts type 2 diabetes
    Cho NH Diabetes Care 30 2566-2568 [2007]
  • -alcoholic fatty liver disease
    Angulo P J Gastroenterol Hepatol 17 186-190 [2002]